dr. konduri on sequencing therapy in egfr nsclc
Published 5 years ago • 92 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
5:10
sequencing egfr-targeted therapies in nsclc
-
1:12
dr. konduri discusses promise of ngs testing in nsclc
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
1:00
dr. konduri addresses unanswered questions in nsclc
-
3:57
sequencing with osimertinib in egfr-positive nsclc
-
3:17
egfr resistance mechanisms and sequencing strategies
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
5:45
egfr tki sequencing
-
1:58
dr. bazhenova on sequencing beyond progression in egfr-mutant nsclc
-
8:31
resistance mechanisms and sequencing for egfr nsclc
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
1:21
dr. kris on the fda approval of dacomitinib in egfr nsclc
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
0:42
ngs vs pcr for egfr genotyping in nsclc
-
1:15
dr. aggarwal on triplet therapy in egfr-mutant lung cancer
-
3:41
egfr inhibitors as adjuvant therapy in nsclc
-
1:40
dr. kris on predicting benefit with osimertinib in egfr nsclc